<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Lepirudin; Hirudins; Bivalirudin" /><meta name="IX" content="Lepirudin; Hirudins; Bivalirudin" /><title>Hirudins: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="69372.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="69372.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=69372.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2760.htm">2.8 Anticoagulants and protamine</a> &gt; <a href="2761.htm">2.8.1 Parenteral anticoagulants</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129019.htm" title="Previous: DANAPAROID SODIUM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129014.htm" title="Next: BIVALIRUDIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301002.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bivalirudin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Antithrombotic Agents 20:12 &gt; Anticoagulants 20:12.04 &gt; Direct Thrombin Inhibitors 20:12.04.12</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301011.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lepirudin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Antithrombotic Agents 20:12 &gt; Anticoagulants 20:12.04 &gt; Direct Thrombin Inhibitors 20:12.04.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17816-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Bivalirudin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: B &gt; Interactions of Bivalirudin</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/19770-g.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Lepirudin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: L &gt; Interactions of Lepirudin</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="129014.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BIVALIRUDIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Hirudins</p></div></li><li><a href="129015.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Angiox®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Hirudins &gt; BIVALIRUDIN</p></div></li><li><a href="69373.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">LEPIRUDIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants &gt; Hirudins</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22lepirudin%22%22hirudins%22%22bivalirudin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0929.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lepirudin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a504008.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bivalirudin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; B</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a504017.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lepirudin</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; L</p></div></li></ul><ul><li><h3>Injectable Drugs Guide (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/b05-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bivalirudin</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; B</p></div></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/L05-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lepirudin</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; L</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/17816-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bivalirudin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19770-g.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lepirudin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01310.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bivalirudin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; B &gt; BI</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E14E3E0R0D803.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Bivalirudin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; B</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D854.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hirudins</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; H</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E10E3E0R0D803.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Lepirudin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; L</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_69372">Hirudins</h1><?highlighter on?><div id="pC" class="jN"><div><p><b><span>Lepirudin</span></b>, a recombinant hirudin, is licensed for anticoagulation
in patients with Type II (immune) heparin-induced thrombocytopenia
who require parenteral antithrombotic treatment. The dose of <span>lepirudin</span> is adjusted according to activated partial thromboplastin
time (APTT). <b><span>Bivalirudin</span></b>, a hirudin analogue, is a
thrombin inhibitor which is licensed for unstable angina or non-ST-segment
elevation myocardial infarction in patients planned for urgent or
early intervention, and as an anticoagulant for patients undergoing
percutaneous coronary intervention (including patients with ST-segment
elevation myocardial infarction undergoing primary percutaneous coronary
intervention—see also <a title="BNF:topic: Management of ST-segment elevation myocardial infarction" href="204270.htm#_204270">section 2.10.1</a>); bivalirudin
should be administered in combination with aspirin and clopidogrel.
The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790"><i>Scottish Medicines
Consortium</i></a> has advised (November 2008) that bivalirudin (<span class="cZ">Angiox</span>®) is accepted for restricted use within NHS Scotland for patients
with acute coronary syndromes planned for urgent or early intervention
who would have been considered for treatment with unfractionated heparin
in combination with a glycoprotein IIb/IIIa inhibitor; it should not
be used as an alternative to heparin alone. The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790"><i>Scottish Medicines
Consortium</i></a> has advised (August 2010) that bivalirudin (<span class="cZ">Angiox</span>®) is accepted for restricted use within NHS Scotland as an anticoagulant
in patients undergoing percutaneous coronary intervention who would
have been considered for treatment with unfractionated heparin in
combination with a glycoprotein IIb/IIIa inhibitor; it should not
be used as an alternative to heparin alone.</p><div id="_218766"><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Bivalirudin for the treatment of ST-segment elevation
myocardial infarction (July 2011)</h3><p>  Bivalirudin in combination with aspirin and clopidogrel is
recommended for the treatment of adults with ST-segment elevation
myocardial infarction undergoing primary percutaneous coronary intervention.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_129014"><a href="129014.htm" title="BIVALIRUDIN">BIVALIRUDIN</a></li><li id="_69373"><a href="69373.htm" title="LEPIRUDIN">LEPIRUDIN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129019.htm">Previous: DANAPAROID SODIUM</a> | <a class="top" href="69372.htm#">Top</a> | <a accesskey="]" href="129014.htm">Next: BIVALIRUDIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>